WFH Humanitarian Aid Program factor makes difference in Venezuela

In 2020, a 21-year-old man with severe hemophilia B from Cojedes, Venezuela, was hospitalized with hip pain and significantly reduced mobility in his leg. Fortunately, he was given factor which was donated by the WFH Humanitarian Aid Program—and he was able to make a full recovery and avoid permanent joint damage.

The patient had been injured in a car accident ten days before, and his condition had worsened to the point where, when he visited the hospital, he had limited mobility in his leg. An ultrasound indicated that he had a hematoma of a pelvic muscle. An initial dose of 3,000 IUs of factor was given, followed by a therapeutic dose of 1,000 IUs every 24 hours for three days. The WFH Humanitarian Aid Program donated factor immediately improved his condition, and he was soon discharged from the hospital. He is now receiving physiotherapy, and is expected to make a full recovery. He will also retain full mobility in his leg, which means that—unlike many people in developing countries—the accident he was involved in will not result in a permanent reduction to his quality of life.

In 2020, the WFH Humanitarian Aid Program donated nearly 7 million IUs of factor to Venezuela. Since 2015, over 95 million IUs have been given to the South American country, allowing patients with a bleeding disorder to enjoy a better quality of life. To find out more about the WFH Humanitarian Aid Program, please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda.  To learn more about the WFH Humanitarian Aid Program, visit